Growth Metrics

Biofrontera (BFRIW) Receivables - Other (2020 - 2025)

Biofrontera has reported Receivables - Other over the past 6 years, most recently at $4.8 million for Q4 2025.

  • Quarterly results put Receivables - Other at $4.8 million for Q4 2025, down 9.43% from a year ago — trailing twelve months through Dec 2025 was $4.8 million (down 9.43% YoY), and the annual figure for FY2025 was $4.8 million, down 9.43%.
  • Receivables - Other for Q4 2025 was $4.8 million at Biofrontera, up from $200000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for BFRIW hit a ceiling of $6.1 million in Q3 2022 and a floor of $56000.0 in Q3 2021.
  • Median Receivables - Other over the past 5 years was $2.9 million (2022), compared with a mean of $2.6 million.
  • Biggest five-year swings in Receivables - Other: surged 10792.86% in 2022 and later crashed 95.44% in 2024.
  • Biofrontera's Receivables - Other stood at $100000.0 in 2021, then surged by 3558.0% to $3.7 million in 2022, then dropped by 23.46% to $2.8 million in 2023, then skyrocketed by 89.29% to $5.3 million in 2024, then decreased by 9.43% to $4.8 million in 2025.
  • The last three reported values for Receivables - Other were $4.8 million (Q4 2025), $200000.0 (Q1 2025), and $5.3 million (Q4 2024) per Business Quant data.